Comparison between Bio Medica Laboratories IPO and Neochem Bio IPO.
Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Neochem Bio IPO is a SME Bookbuilding proposed to list at NSE SME.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Vivro Financial Services Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Neochem Bio IPO is up to ₹42.69 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Neochem Bio IPO is ₹98.00 per share.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹132.00 per share | ₹93.00 per share |
| Issue Price (Upper) | ₹139.00 per share | ₹98.00 per share |
| Issue Price (Final) | ₹139.00 per share | ₹98.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1200 shares |
| Fresh Issue Size | 32,06,000 shares | 43,56,000 shares |
| Fresh Issue Size (Amount) | up to ₹44.56 Cr | up to ₹42.69 Cr |
| OFS Issue Size | 3,77,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹5.24 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,83,000 shares | 43,56,000 shares |
| Issue Size Total (Amount) | up to ₹49.80 Cr | up to ₹42.69 Cr |
Bio Medica Laboratories IPO opens on May 21, 2026, while Neochem Bio IPO opens on Dec 02, 2025. The closing date of Bio Medica Laboratories IPO and Neochem Bio IPO is May 25, 2026, and Dec 04, 2025, respectively.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Anchor Bid Date | Dec 01, 2025 | |
| Issue Open | May 21, 2026 | Dec 02, 2025 |
| Issue Close | May 25, 2026 | Dec 04, 2025 |
| Basis Of Allotment (Tentative) | May 26, 2026 | Dec 05, 2025 |
| Initiation of Refunds (Tentative) | May 27, 2026 | Dec 08, 2025 |
| Credit of Share (Tentative) | May 27, 2026 | Dec 08, 2025 |
| Listing date (Tentative) | May 29, 2026 | Dec 09, 2025 |
| Anchor Lockin End date 1 | Jan 04, 2026 | |
| Anchor Lockin End date 2 | Mar 05, 2026 |
Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Neochem Bio IPO P/E ratio of 15.85.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.84 | 91.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.03 | 15.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹174.79 Cr. | ₹167.78 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 48.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 41.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 1.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.67 | ₹6.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 48.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Neochem Bio IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 8,71,200 shares in Neochem Bio IPO.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 13,03,200 shares |
| Market Maker Reservation | 1,89,000 shares | 2,32,800 shares |
| QIB | 36,000 shares | 8,71,200 shares |
| NII | 17,55,000 shares | 6,55,200 shares |
| RII | 17,92,000 shares | 15,26,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,83,000 shares | 43,56,000 shares |
Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Neochem Bio IPO subscribed 10.88x.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| QIB (times) | 15.94x | 21.97x |
| NII (times) | 1.30x | 21.15x |
| Big NII (times) | 0.86x | 25.78x |
| Small NII (times) | 2.19x | 11.88x |
| RII (times) | 2.92x | 9.42x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.26x | 10.88x |
